A new study has suggested that an overlooked nutrient that is easily added to the diet could reduce the risk of dementia and ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

An online dementia-focused lifestyle program has “significantly” improved cognition of at-risk Australians over three years ...

New research from The American Journal of Clinical Nutrition has indicated that choline intake may be associated with lower odds of developing dementia ...

Experts have suggested that someone's lifestyle habits could influence the likelihood of developing dementia in the long term ...

The Austin, Texas-based biotech revealed that simufilam failed its first phase 3 test in mild-to-moderate Alzheimer's and a second study has now been halted, leading to an 84% drop in its share price.

Topline data were published from a phase 2b/3 study evaluating blarcamesine for the treatment of early Alzheimer disease.

In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD ... memantine's efficacy in treating moderate-to ...

Prescribing physical activity to older adults reduces risk factors for chronic disease and improves functional independence, ...

Learn about the 7 stages of dementia, from no impairment to end stage. Understand the signs and symptoms of each stage and ...